Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Status:
Completed

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

This Phase II clinical study is to test safety and efficacy of BT061 against psoriasis given as repeated doses.

Phase 2

Biotest